tiprankstipranks
Advertisement
Advertisement

VOR Stock Latest News

Vor Bio reports Q2 EPS ($1.16) vs. ($251.24) last year
The FlyVor Bio reports Q2 EPS ($1.16) vs. ($251.24) last year
2d ago
VOR
Vor Bio sees cash runway into early 2029
PremiumThe Fly
Vor Bio sees cash runway into early 2029
2d ago
VOR
Vor Biopharma Adds Industry Veteran David Zaccardelli to Board
PremiumCompany Announcements
Vor Biopharma Adds Industry Veteran David Zaccardelli to Board
1M ago
8K
VOR
Vor Biopharma shareholders back directors and governance measures
PremiumCompany Announcements
Vor Biopharma shareholders back directors and governance measures
2M ago
8K
VOR
Vor Bio gains boost from telitacicept IgA nephropathy approval
PremiumCompany Announcements
Vor Bio gains boost from telitacicept IgA nephropathy approval
2M ago
8K
VOR
Vor Bio announces China NMPA approval for telitacicept
PremiumThe FlyVor Bio announces China NMPA approval for telitacicept
2M ago
VOR
Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar
Premium
Company Announcements
Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar
2M ago
VOR
Vor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
Premium
Ratings
Vor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
3M ago
VOR
Vor Bio price target raised to $18 from $15 at Wedbush
PremiumThe Fly
Vor Bio price target raised to $18 from $15 at Wedbush
3M ago
VOR
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
PremiumCompany Announcements
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
3M ago
VOR
Vor Bio files to sell 5.34M shares of common stock for holders
PremiumThe Fly
Vor Bio files to sell 5.34M shares of common stock for holders
4M ago
VOR
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
PremiumWeekend Updates
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
4M ago
HDB
STT
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
PremiumWeekend UpdatesBj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
4M ago
BJ
ASO
Vor Bio price target lowered to $31 from $32 at H.C. Wainwright
Premium
The Fly
Vor Bio price target lowered to $31 from $32 at H.C. Wainwright
4M ago
VOR
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
Premium
Weekend Updates
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
4M ago
SG
VOR
Vor Bio price target raised to $15 from $9 at Wedbush
PremiumThe Fly
Vor Bio price target raised to $15 from $9 at Wedbush
5M ago
VOR
Vor Bio price target lowered to $40 from $55 at Stifel
PremiumThe Fly
Vor Bio price target lowered to $40 from $55 at Stifel
5M ago
VOR
Vor Bio price target lowered to $40 from $55 at Stifel
PremiumThe Fly
Vor Bio price target lowered to $40 from $55 at Stifel
5M ago
VOR
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
PremiumRatings
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
5M ago
VOR
Vor Bio doses first patient in UPSTREAM SjD study
PremiumThe FlyVor Bio doses first patient in UPSTREAM SjD study
5M ago
VOR
Vor Bio initiated with a Buy at Jefferies
Premium
The Fly
Vor Bio initiated with a Buy at Jefferies
5M ago
VOR
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
Premium
Ratings
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
5M ago
VOR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >